• Tue, December 26, 2017

by: WOPRAI

Michael Gaugler Upgraded (UTL) to Strong Buy on, Dec 26th, 2017

  • Tue, January 2, 2018

by: WOPRAI

Akil Marsh Downgraded (SND) to Hold on, Jan 2nd, 2018

by: WOPRAI

Shahriar Pourreza Downgraded (AWK) to Hold on, Jan 2nd, 2018

by: WOPRAI

Robbie Marcus Upgraded (SYK) to Buy on, Jan 2nd, 2018

by: WOPRAI

George Staphos Upgraded (BRC) to Strong Buy on, Jan 2nd, 2018

by: WOPRAI

C Muse Upgraded (TER) to Buy on, Jan 2nd, 2018

by: WOPRAI

Ami Fadia Initiated (TEVA) at Sell and Held Target at $15 on, Jan 2nd, 2018

by: WOPRAI

Robbie Marcus Upgraded (BAX) to Buy on, Jan 2nd, 2018

by: WOPRAI

Bob Hopkins Upgraded (BAX) to Strong Buy on, Jan 2nd, 2018

by: WOPRAI

Meyer Shields Downgraded (ALL) to Sell on, Jan 2nd, 2018

by: WOPRAI

Tim Nollen Downgraded (AMCX) to Hold on, Jan 2nd, 2018

by: WOPRAI

Brian Abrahams Upgraded (BCRX) to Buy on, Jan 2nd, 2018

by: WOPRAI

Jimmy Bhullar Downgraded (BHF) to Sell on, Jan 2nd, 2018

by: WOPRAI

Shahriar Pourreza Downgraded (AEP) to Strong Sell on, Jan 2nd, 2018

  • Wed, December 20, 2017

by: WOPRAI

Jorge Beristain Downgraded (CENX) to Hold on, Dec 20th, 2017

by: WOPRAI

Chris Olin Upgraded (X) to Strong Buy on, Dec 20th, 2017

by: WOPRAI

Debjit Chattopadhyay Initiated (BOLD) at Strong Buy and Held Target at $37 on, Dec 20th, 2017

by: WOPRAI

Duffy Fischer Initiated (WLKP) at Hold and Held Target at $26 on, Dec 20th, 2017

by: WOPRAI

Michael Dahl Initiated (WMS) at Hold and Held Target at $24 on, Dec 20th, 2017

by: WOPRAI

Daniel Mckenzie Upgraded (UAL) to Strong Buy on, Dec 20th, 2017

by: WOPRAI

Shlomo Rosenbaum Initiated (SPGI) at Hold and Held Target at $186 on, Dec 20th, 2017

by: WOPRAI

Chris Olin Upgraded (STLD) to Strong Buy on, Dec 20th, 2017

by: WOPRAI

Andrew Schenker Downgraded (THC) to Sell on, Dec 20th, 2017

by: WOPRAI

Peter Stabler Initiated (TTD) at Buy and Held Target at $6 on, Dec 20th, 2017

by: WOPRAI

Nick Setyan Upgraded (WEN) to Buy on, Dec 20th, 2017

by: WOPRAI

Dane Leone Initiated (VYGR) at Strong Buy and Held Target at $32 on, Dec 20th, 2017

by: WOPRAI

Paul Coster Upgraded (VREX) to Hold on, Dec 20th, 2017

by: WOPRAI

Shelby Tucker Initiated (VST) at Buy and Held Target at $21 on, Dec 20th, 2017

by: WOPRAI

Shlomo Rosenbaum Initiated (ARMK) at Strong Buy and Held Target at $50 on, Dec 20th, 2017

by: WOPRAI

Curt Woodworth Upgraded (AA) to Buy on, Dec 20th, 2017

by: WOPRAI

Isaac Ro Upgraded (ZBH) to Hold on, Dec 20th, 2017

by: WOPRAI

Gena Wang Initiated (BCRX) at Hold and Held Target at $6 on, Dec 20th, 2017

  • Thu, December 21, 2017

by: WOPRAI

Michael Linenberg Upgraded (ALGT) to Strong Buy on, Dec 21st, 2017

by: WOPRAI

Hamzah Mazari Initiated (BFAM) at Hold and Held Target at $95 on, Dec 21st, 2017

by: WOPRAI

Matthew Clark Initiated (BANC) at Buy and Held Target at $26 on, Dec 21st, 2017

by: WOPRAI

Michael Yee Downgraded (AXON) to Hold on, Dec 21st, 2017

by: WOPRAI

Richard Shane Initiated (ABR) at Hold and Held Target at $8.5 on, Dec 21st, 2017

by: WOPRAI

Koji Ikeda Initiated (ADSK) at Buy and Held Target at $135 on, Dec 21st, 2017

by: WOPRAI

Jake Civiello Initiated (VLY) at Buy and Held Target at $14 on, Dec 21st, 2017

by: WOPRAI

Thomas Gallagher Upgraded (VOYA) to Buy and Increased Target to $60 on, Dec 21st, 2017

by: WOPRAI

Mark Breidenbach Initiated (BLUE) at Hold on, Dec 21st, 2017

by: WOPRAI

Harsh Kumar Initiated (SWKS) at Buy and Held Target at $115 on, Dec 21st, 2017

by: WOPRAI

James Mitchell Upgraded (WFC) to Strong Buy on, Dec 21st, 2017

by: WOPRAI

Peter Winter Upgraded (TCBI) to Buy on, Dec 21st, 2017

  • Fri, December 22, 2017

by: WOPRAI

Julien Dumoulin-Smith Downgraded (SRE) to Hold on, Dec 22nd, 2017

by: WOPRAI

Andy Barish Downgraded (WING) to Sell on, Dec 22nd, 2017

by: WOPRAI

Andy Barish Upgraded (TXRH) to Hold on, Dec 22nd, 2017

by: WOPRAI

Michael Feniger Initiated (WCN) at Strong Buy and Held Target at $80 on, Dec 22nd, 2017

Gena Wang Initiated (BCRX) at Hold and Held Target at $6 on, Dec 20th, 2017

Gena Wang of Barclays, Initiated "BioCryst Pharmaceuticals, Inc." (BCRX) at Hold and Held Target at $6 on, Dec 20th, 2017.

Gena has made no other calls on BCRX in the last 4 months.



There are 3 other peers that have a rating on BCRX. Out of the 3 peers that are also analyzing BCRX, 1 agrees with Gena's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Brian Abrahams of "RBC Capital" Initiated at Hold and Held Target at $6 on, Friday, September 15th, 2017


These are the ratings of the 2 analyists that currently disagree with Gena

  • Jessica Fye of "JP Morgan" Upgraded from Hold to Buy on, Wednesday, September 6th, 2017
  • Maury Raycroft of "Jefferies" Upgraded from Hold to Strong Buy on, Wednesday, September 6th, 2017